Immunocytochemical localization of proANF 1-30, proANF 31-67 and atrial natriuretic factor in the kidney  by Ramirez, German et al.
Kidney International, Vol. 41(1992), pp. 334—341
Immunocytochemical localization of proANF 1-30, proANF
31-67 and atrial natriuretic factor in the kidney
GERMAN RAMIREZ, SABIHA R. SABA, JOHN R. DIETZ, and DAVID L. VESELY
Divisions of Nephrology, Hypertension, and Endocrinology, Departments of Internal Medicine, Pathology, Physiology and Biophysics, James
A. Haley Veterans Hospital, and University of South Florida Health Sciences Center, Tampa, Florida, USA
Immunocytochemical localization of proANF 1.30, proANF 31-67 and
atrial natriuretic factor in the kidney. ProANF [1-30 first 30 amino acids
(a.a) of the 126 a.a atrial natriuretic factor (ANF) prohormone],
ProANF 31-67 (a.a 31-67) as well as atrial natriuretic factor (a.a 99-126),
of the ANF prohormone localized to the sub-brush border of the pars
convoluta and pars rectus of the proximal tubules of hydrated and
dehydrated rat kidneys with immunoperoxidase staining. Immunofluo-
rescent studies revealed that each of these peptides and especially
ProANF 3 1-67 had a strong predilection for the perinuclear region in the
proximal and distal tubules. ProANFs 1-30, 31-67, and 99-126 (that is,
ANF) also localized with both immunoperoxidase and immunofluores-
cent staining to the cortical collecting ducts, glomeruli, peritubular, and
interstitial blood vessels. ProANF 31-67 immunoperoxidase staining
was particularly striking in the elastica of the small and large interstitial
arteries, The whole prohormone being present was suggested by
immunological recognition in the rat kidney of both the N-terminus and
C-terminus of the ANF prohormone by radioimmunoassays. The con-
centration of the N-terminus in the kidney was 1.0 0.03 ng/g of kidney
weight, while the C-terminus of the ANF prohormone concentration
was 0.4 0.01 ng/g of kidney tissue. These findings of a sub-brush
border and perinuclear location of the N-terminal and C-terminal ANF
prohormone peptides suggest that the atrial natriuretic factor prohor-
mone may be synthesized in and/or the respective peptides are captured
by the proximal tubules, but also to a lesser extent by the distal tubules
of the kidney.
The newly-described atrial natriuretic peptide hormonal sys-
tem in both humans and animals appears to play an important
role n sodium and water excretion [1]. This hormonal system
consists of a 126 amino acid (a.a) prohormone which circulates
as a 98 a.a. N-terminus (ProANF 1-98) and a C-terminus
consisting of a.a. 99-126 in humans [2—7] and animals [8—10].
Atrial natriuretic factor (ANF), the 28 a.a. carboxy (C)-terminal
end of this prohormone, and at least two peptides from the
N-terminus of the ANF prohormone consisting of a.a. 1-30
(Pr0ANF 1-30; Long acting sodium stimulator) and a.a. 3 1-67
(ProANF 31-67; vessel dilator) have similar vasodilatory, so-
dium, and water excreting properties [11]. ProANF 31-67
inhibits sodium reabsorption in inner medullary collecting duct
(IMCD) cells equal to ANF at physiological concentrations
(10-11 M), but their mechanisms of action appear different [12].
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ProANF 31-67, in contradistinction to ANF, appears to inhibit
the Na/K-ATPase in the IMCD [12].Whether ProANF 1-30
and ProANF 31-67 localize in the kidney is not known, and the
renal distribution of these peptides relative to ANF has not
been determined. The present investigation was designed to
determine the presence and location of ProANF 1-30, ProANF
31-67, and ANF utilizing immunoperoxidase and immunofluo-
rescent staining for each of these atrial natriuretic peptides.
Methods
Tissues utilized in this investigation were obtained from male
Sprague-Dawley rats weighing 250 to 300 g. All experiments
were conducted in accordance with the NIH Guiding Principles
for the Care and Use of Laboratory Animals and approved by
the Committees for Animal Care and Use at both the University
of South Florida for Health Sciences and the James A. Haley
Veterans Hospital (Tampa).
Tissue preparation
Dehydrated rats as well as hydrated rats were utilized in the
present investigation since dehydration has previously been
reported to decrease the concentration of ANF in rat cardiac
atria and plasma suggesting decreased ANF synthesis with
dehydration [131. Thus, the effect of dehydration on the im-
munocytochemical localization of ProANF 1-30, ProANF 31-
67, and ANF in rat kidney was incorporated into the present
investigation to determine if the kidneys of dehydrated animals
might also have decreased immunofluorescent staining versus
hydrated animals. Dehydration was achieved by the intrave-
nous injection of 0.1 ml of furosemide which resulted in diuresis
of 3 ml of urine over a 20 minute period prior to sacrifice. The
hydrated rats had a continuous infusion of isotonic saline (3 ml)
over this same 20 minute period. Both the hydrated and
dehydrated rats were anesthesized with sodium pentabarbitol
(50 mg/kg i.p.). When comfortably anesthetized, both groups
had catheters placed in the jugular vein for the respective
infusions and in both ureters to monitor urine flow. After the
respective 20 minute period of hydration and dehydration the
kidneys were removed and 3 mm slices of the respective
kidneys fixed in 10% formalin for 24 hours, processed, and
imbedded in paraffin wax. Sections were cut at 3 m and
mounted on acid cleaned glass slides, dried overnight in a 50°C
oven, and embedded in paraffin wax.
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Immunoperoxidase method
After deparaffinization and rehydration with phosphate buff-
ered saline, pH 7.2, sections were stained for ProANF 1-30,
ProANF 3 1-67, and ANF by the avidin-biotin peroxidase com-
plex (ABC) technique [14] using a Vectstain kit® (Victor Labs,
Burlingame, California, USA). Sections were incubated for one
hour at 24°C in a humidity chamber with respective primary
antibody diluted (1:100 to 1:300) with phosphate buffered saline
and then after rinsing, incubated again in the humidity chamber
for 30 minutes with biotinylated antibody. The slides were then
rinsed followed by a final incubation for 30 minutes in ABC in
a humidity chamber. Controls for the immunoperoxidase stain-
ing included: a) substitution for primary antibody with normal
rabbit serum and b) pre-incubation of primary antibody with
excess of ProANF 1-30, ProANF 31-67 and/or ANF in their
respective immunoperoxidase assays for 24 hours at 37°C.
Immunofluorescence methods
Atrial natriuretic factor (ANF) immunofluorescence in the
kidney was determined by an ANF immunofluorescent kit from
Peninsula Laboratories (Belmont, California, USA) while
ProANF 1-30 and ProANF 3 1-67 immunofluorescent antibodies
were also obtained from Peninsula Laboratories and utilized as
follows: Sections of snap-frozen kidneys of normally hydrated
and dehydrated rats were cut at 4 microns and placed on glued
slides, fixed in acetone for 10 minutes before applying 200 l of
the respective primary antiserum (diluted 1:20 to 1:200) or a
negative control to the tissue sections. The negative controls for
the immunofluorescent studies were 50 pg of synthetic ProANF
1-30, ProANF 3 1-67, or ANF pre-incubated with their respec-
tive antiserum. The slides with the respective primary antiser-
ums or negative controls were then incubated at 4°C overnight
in a humidity chamber. The following morning, a secondary
antibody (1:100 dilution) in the form of fluorescent conjugated
goat anti-rabbit gamma globulin, 200 d, was added. These
slides were then incubated at room temperature (24°C) in a
humidity chamber for one hour followed by washing of the
slides with phosphate buffered saline, and mounted with Aqua-
mount.
Cross reactivity of ProANF 1-30, ProANF 31-67, and ANF
Cross reactivities of the various antisera raised in rabbits to
determine their specificity were determined by comparative
radioimmunoassays utilizing pure synthetic peptides ProANF
1-30, ProANF 31-67, ProANF 1-67, ProANF 1-98, and ANF
(that is, amino acids 99-126 of the 126 a.a. prohormone)
synthesized and assayed by Peninsula Laboratories, Inc (Bel-
mont, California, USA). ProANF 1-30 antisera cross reactivity
with pure synthetic ProANF 1-30 was 100% while its cross
reactivity with ANF was 0%. ProANF 1-30 cross reactivity
with ProANF 1-67 was 22%. ProANF 31-67 antisera had 100%
cross reactivity with pure synthetic ProANF 31-67, 95% cross
reactivity with synthetic ProANF 1-98, 5% cross reactivity with
ProANF 1-67 and 0% cross reactivity with ANF. The antisera
to ANF had 100% cross reactivity with ANF, and 0% cross
reactivity with either ProANF 1-30 or ProANF 31-67.
Although the ProANF 31-67 antisera had a 95% cross reac-
tivity with synthetic ProANF 1-98, when this cross reactivity
was subjected to further testing with G-50 Fine Sephadex gel
permeation chromatography to determine the actual molecular
weight of the peptides recognized, the majority (96%) of this
antisera's recognition was a 3900 molecular weight peptide
consistent with ProANF 31-67 (the actual molecular weight of
ProANF 31-67 is 3878) [7]. Only 4% of what this antisera
recognized was a 10,000 molecular weight peptide consistent
with ProANF 1-98 [7]. The ProANF 1-30 antisera, on the other
hand, when subjected to the same gel permeation studies
recognized almost 100% the 10,000 molecular weight peptide
consistent with ProANF 1-98. The ANF antisera recognized
only a 3000 molecular weight peptide consistent with ANF [7].
The ANF antisera does not recognize ProANF 1-98 [7]. None of
the antisera (ProANF 1-30, ProANF 3 1-67, or ANF) recognized
a 13,000 molecular weight peptide (the molecular weight of
ProANF 1-126) [7]. A pure synthetic 126 amino acid ANF
prohormone is not available at present which is able to deter-
mine its cross reactivity with these antisera to be absolutely
sure, however, that none of these antisera recognize ProANF
1-126.
Radioimmunoassays to detect ANF prohormone
The labelled [1125] and unlabelled prohormone atrial natri-
uretic peptides utilized for the radioimmunoassays described
below were obtained from Peninsula Laboratories. Radioimmu-
noassay to measure the 98 amino acid (a.a.) N-terminus of the
prohormone was devised to amino acids 1-30 of the 126 a.a.
prohormone, while the C-terminal assay measures a.a. 99-126
of the prohormone, that is, ANF as previously described by our
laboratory [7]. The tissue samples were placed in 5 ml ethyl-
enediaminetetraacetic acid (EDTA) tubes and homogenized
with a Polytron homogenizer (Brinkman Instruments, West-
bury, New York, USA) using 10 second bursts in 5 ml of cold
0.03 Tris-HCI (pH 7.6), and centrifuged at 3000 x g in a
refrigerated ultracentrifuge at 4°C for 30 minutes. Following
homogenization, the tissue samples were immediately centri-
fuged at 3000 X g for 15 minutes. After centrifugation each
tissue was extracted with 100% ethanol (1:1 dilution), vortexed,
and allowed to stand at 4°C for 30 minutes. Following 30
minutes at 4°C, the samples were centrifuged at 3000 x g for 15
minutes with the supernatants taken to dryness via controlled
nitrogen flow. The samples were then ready for radioimmuno-
assay. Our ProANF 1-30 radioimmunoassay immunologically
recognizes the 98 a.a. N-terminus of the ANF prohormone as
characterized by G-50 Sephadex gel-permeation chromatogra-
phy [7]. Our C-terminal ANF prohormone radioimmunoassay
recognizes the 3000 molecular weight C-terminal end of the
prohormone [7]. The intraassay coefficient of variation for the
N-terminal and C-terminal ANF prohormone radioimmunoas-
says were 4.8%, and 5.7%, respectively. The interassay coeffi-
cient of variation was 8% for the N-terminal assay, while the
C-terminal ANF prohormone radioimmunoassay interassay
variation was 6.9%. The respective IC50 were 180 and 11
fmol/tube, while the lowest detectable concentrations were 40
and 1.4 fmol for the N-terminal and C-terminal ANF prohor-
mone radioimmunoassays, respectively.
Results
ProANF 1-30's immunoperoxidase staining was very strong(++++) in granules of the pars convoluta of the proximal
tubules in the sub-brush border of kidneys from both normally
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Fig. 1. Immunoperoxidase proANF 1-30 (first
30 amino acids of 126 amino acid atrial
natriuretic factor hormone) localization in rat
kidneys. The strongest proANF 1-30
immunoperoxidase staining is present in the
sub-brush border granules of the pars
convoluta of the proximal tubules (arrows, A).
Weaker staining of ProANF 1-30 is also
present in the pars recta of the proximal
tubules (arrowheads). Distal convoluted
tubules are only weakly positive (*). Fig lA
magnification: 375x B. Proximal convoluted
tubules at higher magnification (940x). Brush
border (arrows) and sub-brush border staining
(arrowheads) are visible in B. The cost to
reproduce this color photomicrograph was
kindly provided by Merck, Sharp, and
Dohme.
Fig. 2. immunofluorescent proANF 1-30
localization in rat kidneys. ProANF 1-30
localized to the glomeruli, the lining of the
capillary lumen and mesangium (arrows), the
peritubular capillaries (insert left lower
corner, arrows) and the interstitial blood
vessels (big arrow). Weak staining was
present in the tubules (z). (Magnification:
l000x)
hydrated and dehydrated rats (Fig. 1). Weaker (+ +) immuno- tubules (Fig. 2). There was a very weak immunofluorescence in
peroxidase staining of ProANF 1-30 was observed in the pars the distal tubules, but no immunofluorescence of ProANF 1-30
recta of the proximal tubules (Fig. 1). Weak (+) immunoper-
oxidase staining for ProANF 1-30 was present in the distal
tubules, glomeruli, peritubular and interstitial blood vessels
(Fig. 1). Weak focal staining was also present in the collecting
tubules of cortical and outer medullary nephrons. No ProANF
1-30 was detectable in the inner medullary collecting ducts with
in the inner medullary collecting ducts. The immunofluores-
cence and immunoperoxidase studies with ProANF 1-30 thus
revealed a similar staining distribution as outlined in Table 1.
ProANF 31-67 had a similar strong (++++) immunoper-
oxidase staining pattern in the pars convoluta portion of the
proximal tubules as ProANF 1-30 (Fig. 3). ProANF 31-67
immunoperoxidase staining pattern in the pars recta of the
proximal tubules appeared to be stronger than that seen with
ProANF 1-30. ProANF 3 1-67's immunoperoxidase staining of
blood vessels was much stronger than ProANF 1-30 and was
immunoperoxidase staining.
Immunofluorescent studies revealed moderate staining of
ProANF 1-30 in glomeruli, peritubular, and interstitial blood
vessels and weak (+) immunofluorescence in the proximal
—'
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Table 1. Immunocytological localization of proANF 1-30, proANF
31-67 and ANF in the Kidney
ProANF ProANF
1-30 31-67 ANF
IP IF IP IF IP IF
Proximal tubules
Pars convoluta ++++ ++ ++++ ++ +++ ++++
Pars rectus ++ +÷ +++ ++ ++ ++++
Distal Tubules + + + + + + + + + +
Glomeruli + + + + + + + + +
Peritubular vessels -I- + + + + + + + +
Interstitial vessels + + + + + + + + + + + +
Cortex collecting tubules + + + + + + + + +
Outer medullary + — + + + + + +
nephrons
Inter medullary 0 0 0 0 0 0
nephrons
IP: Immunoperoxidase stain graded 0 to ÷ ÷ + +, with ÷ + + + being
the strongest staining observed.
IF: Immunofluorescent stain graded 0 to + + + +, with + + + + being
the strongest IF stain.
particularly striking in the elastica of the small and large
interstitial arteries (Fig. 3). Moderate ProANF 31-67 immuno-
peroxidase staining was also found in the media of these vessels
(Fig. 3).
Immunofluorescent ProANF 3 1-67 was present in the proxi-
mal tubules, with a strong predilection for the perinuclear
region (Fig. 4). Perinuclear staining was also seen in distal
and/or collecting ducts of cortical region (Fig. 4). As compared
with ProANF 1-30 (Fig. 2), ProANF 3 1-67 had a stronger
immunofluorescent pattern in glomeruli and interstitial blood
vessels (Fig. 4). There was no ProANF 3 1-67 immunofluores-
cent staining in the collecting ducts of the medullary region. The
immunofluorescence and immunoperoxidase staining patterns
with ProANF 3 1-67 were similar throughout the kidney as
outlined in Table 1.
Moderate immunoperoxidase atrial natriuretic factor (ANF)
staining was present in the glomerular tuft, interstitial vascular
endothelium and wall including peritubular vascular network
(Figs. 5 and 6). ANF immunoperoxidase staining was slightly
stronger in proximal convoluted tubules in the normohydrated
versus the dehydrated rat kidneys, but the staining was not as
strong as that seen with ProANF 1-30 (Fig. 1) or ProANF 3 1-67
(Fig. 3). Some cortical and outer medullary collecting tubules
demonstrated alternate cells positivity (Figs. 5 and 6). ANF
immunofluorescence was strong (+ + + +) in the proximal tu-
bules of dehydrated rat kidneys and in the normal kidneys
(+ + +), The normohydrated rat kidneys had strong (+ + +)
ANF immunofluorescence in interstitial blood vessels (Fig. 7).
Weak (+) ANF immunofluorescence was also present in the
distal tubules, glomeruli and peritubular blood vessels of both
the hydrated and dehydrated rat kidneys (Fig. 7). The ANF
immunoperoxidase and immunolluorescent staining patterns
followed a similar distribution as outlined in Table 1. Although
there were minor staining differences between the dehydrated
and normohydrated rats with respect to intensity of stain with
both the immunoperoxidase and immunofluorescent methods
for ProANFs 1-30, 31-67, and ANF, this difference did not
appear to be significant. The distribution of staining between
the dehydrated and normohydrated rats was exactly the same.
There was no immunoperoxidase staining with ProANF 1-30,
ProANF 31-67, or ANF in the kidney when their respective
primary antisera were: 1) substituted with normal rabbit serum;
or 2) when the primary antibody was pre-incubated with excess
of ProANF 1-30, ProANF 31-67 and/or ANF in their respective
immunoperoxidase assays for 24 hours at 37°C, Likewise, there
was no immunofluorescent staining when the negative controls
of 50 g of synthetic ProANF 1-30, ProANF 31-67 or ANF were
pre-incubated with their respective antiserum in the immuno-
fluore scent studies.
All 126 amino acids of the ANF prohormone were immuno-
logically recognized to be present in normally hydrated kidneys
when evaluated by radioimmunoassay. The concentration of
the 98 amino acid N-terminus was 1.0 0.03 ng/g of kidney
tissue while the C-terminus (a.a 99-126 of the prohormone)
concentration was 0.4 0.01 ng/g of kidney tissue. For com-
parison, the concentrations of the N-terminus and C-terminus
of the ANF prohormone in the cardiac atria of these same
animals were 196 40 ng/g of tissue and 189 15 ng/g of tissue,
respectively. It should be pointed out that the ability to immu-
nologically detect the N-terminus or C-terminus of the ANF
prohormone does not necessarily indicate that the whole pro-
hormone is intact or that the ANF prohormone is synthesized in
the kidney. To prove that it is synthesized in the kidney will
require messenger (m) RNA synthesis studies but the present
immunoperoxidase, immunofluorescent, and radioimmunoas-
say studies definitely indicate that the majority of the ANF
prohormone is, indeed, present within the proximal and distal
tubules of the kidney.
Discussion
Immunoperoxidase and immunofluorescent staining localized
ProANF 1-30 and ProANF 3 1-67 from the N-terminus and
ANF, that is the C-terminus of the atrial natriuretic factor
prohormone to the pars convoluta and pars recta of the proxi-
mal convoluted tubules in a sub-brush border location and to a
lesser extent also in the distal tubules. In the rat, the proximal
convoluted tubule can be distinctly divided into an early portion
of the proximal tubule (that is, pars convoluta consisting of
columnar cells) and a terminal portion (pars recta consisting of
cuboidal cells) [15]. Both the pars recta and pars convoluta
contain brush borders composed of a series of microvilli which
project into the lumen [15]. In the present investigation,
ProANF 1-30, ProANF 31-67, and ANF each had stronger
immunoperoxidase staining in the pars convoluta as opposed to
the pars recta of the proximal tubule similar to adenosine
triphosphatase (ATPase) whose activity in the brush border is
known to be greater in the pars convoluta as compared to the
pars recta of the proximal convoluted tubule [15]. This sub-
brush border location of ProANFs 1-30, 3 1-67, and ANF and
the N-terminal and C-terminal ANF prohormone immunoassay
evidence that all 126 a.a. of the ANF prohormone are present
within the kidney suggests that the ANF prohormone may be
synthesized in the kidney in the proximal and distal tubules.
The perinuclear immunofluorescent locations of ProANFs 1-30,
31-67, and ANF in the proximal and distal tubules is similar to
their perinuclear location of synthesis and storage in the cardiac
myocyte [1]. Further evidence of possible ANF prohormone
synthesis in the kidney has been the recent demonstration of
both the 98 a.a N-terminus (that is, a.a. 1-98) and C-terminus
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Fig. 3. ProANF 31-67 immunoperoxidase
staining in the rat kidney reveals strong
staining of the sub-brush border of proximal
convoluted tubules (A and B, arrowheads),
including a proximal tubule in A originating
directly from the left upper portion of the
glomerulus. The interstitial artery (C) had
strong ProANF 3 1-67 staining of the elastica
with moderate staining of endothelial cells
(arrows) and media (*) The distal tubules and
collecting ducts (arrows in A and B) had weak
staining with no demonstrable staining in
some of the collecting duct cells.
(Magnification: 940x) The cost to reproduce
this photomicrograph was kindly provided by
Merck, Sharp, and Dohme.
Fig. 4. Immunofluorescent ProANF 31-67
localization in perinuclear regions (short
arrows) of both tubules (A), glomerulus (A),
and in the collecting or distal tubules (B).
ProANF 31-67 stained strongly in the
interstitial blood vessels and glomeruli lining
the capillary lumen and mesangium (A, long
arrows). Moderate staining was also present
in the cytoplasm of the tubules (A and B,
arrowheads). (Magnification: 850X)
(a.a 99-126) of the ANF prohormone in the urine of humans [16]
and animals [17] and radioimmunoassay data [18], suggesting
that kidney cells in culture secrete this prohormone into the
culture medium. The finding of urodilatin (that is, a.a. 95-126 of
the ANF prohormone) in the urine would also suggest that ANF
prohormone is being synthesized by the kidney, as the heart is
not known to produce urodilatin [19].
ProANF 1-30, ProANF 31-67, and ANF immunoperoxidase
and immunofluorescent staining were also found in glomeruli,
peritubular, and interstitial blood vessels. Immunofluorescent
staining was stronger than immunoperoxidase staining for
ProANFs 1-30, 3 1-67, and ANF in these vascular tissues,
suggesting that circulating forms of ProANFs 1-30, 31-67, and
ANF might be binding to these vascular tissues in the kidney
rather than being synthesized in the respective kidney vascular
tissues. The difference between the strength of the immunoflu-
orescent and immunoperoxidase staining is not an absolute
indication that these peptides were binding to these tissues,
however, since the amount of staining with immunoperoxidase
depends on the surface area to be stained while immunofluo-
rescence does not depend on surface area. Thus, structures
with a larger surface area such as renal tubules when compared
with endothelium of renal vasculature will have a darker stain
even if both have equal avidity for the same immunoperoxidase
labeled peptide antisera. ProANF 1-30 and ProANF 31-67 do
have distinct and separate binding sites from ANF in vascular
tissues [20]. ProANF 1-30 and ProANF 31-67 do not appear to
bind to either the ANF-A or C-receptors [20]. The finding of
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Fig. 5. Atrial natriuretic factor (ANF)
immunoperoxidase staining of the glomerular
endothelial cells lining the capillary lumen
(short arrows) and mesangium (arrowheads).
Endothelial staining was also present in the
afferent and efferent arterioles (lower left long
arrow). Positive immunoperoxidase staining
for ANF was also present in the proximal
convoluted tubules (double arrows) and
stained to a darker extent in every other cell
(that is, alternate cells) of the collecting duct
(insert upper left (*) (Magnification: l000x)
Publication of this figure in color has been
made possible by a grant from Merck, Sharp
& Dohme, West Point, Pennsylvania, USA.
Fig. 6. Immunoperoxidase localization of
ANF to endothelium (long arrows) of the
interstitial arteriole, artery and peritubular
capillary (A and B). The media of the
interstitial artery also stained positive for
ANF (B, insert **). In the B insert, one can
clearly discern the ANF immunoperoxidase
staining of endothelial cells (arrow). ANF
immunoperoxidase was again seen in the
convoluted tubules (double arrow) and in
alternate cells of collecting ducts (A, *).
(Magnification: 940 x)
ProANF 1-30 and 31-67 in the elastica of the small and large
interstitial arteries suggests that these peptides may be inter-
nalized after binding to their receptors as has previously been
shown to occur for ANF [21]. Receptors for ProANF 1-30,
ProANF 31-67, and ANF have also been found in both the
proximal and distal tubules [221. The intensity of staining in the
tubules by the immunoperoxidase and immunofluorescent
methods as discussed above for vasculature does not differen-
tiate whether their presence is due to receptor binding in the
tubules or due to de novo synthesis.
ANF immunofluorescence was found in both the proximal
and distal convoluted tubules in the present investigation. Its
demonstration in distal convoluted tubules is similar to its
previous demonstration in the distal convoluted tubules of
normal kidneys of humans [23] and rats [24]. Although ANF
immunofluorescence in the proximal convoluted tubules was
not mentioned in the previous studies of normal human and rat
kidneys [23, 24], in a study of kidneys from rats with experi-
mentally produced renal failure, the primary localization was
found in the proximal convoluted tubules with additional im-
munofluorescence in the glomerular efferent and afferent arter-
ies [25]. These findings are similar to that found in normal and
dehydrated kidneys of the present investigation. The data of the
present investigation would suggest that the proximal as well as
the distal convoluted tubules are important sites of ANF's
action and/or synthesis. Atrial natriuretic factor and, to a lesser
extent, ProANF 1-30 and ProANF 31-67 immunoperoxidase
staining was found in every other cell (that is, alternate cells) of
0; -'a;M:4 C i
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Fig. 7. Atrial natriuretic factor (ANF)
immunofluorescence of rat kidney was
prominent in tubules (A, arrow). Weaker ANF
staining was observed in the glomerular
capillary lumen and mesangium (B, arrows).
The interstitial blood vessels of the hydrated
rat stained strongly with ANF (C).
(Magnification: 940x)
the cortical collecting duct. When examined with electron
microscopy, the cortical collecting tubules have been noted to
have alternating dark (intercalated) and light cells [15]. The dark
cells are distinguished by numerous granules and large numbers
of microvesicles in their apical portion, with a large number of
mitochondria within these cells and frequent microvilli on their
luminal surfaces [15]. In contrast, the light cells have few mito-
chondria, granules or microvilli and no microvesicles [15].
ProANF 1-30, ProANF 31-67 and ANF immunoperoxidase stain-
ing appeared to localize to the dark cells, but this could not be
defined with certainty in the present investigation. What could be
determined with certainty was that there was a distinct every other
cell immunoperoxidase localization of these atrial natriuretic pep-
tides, suggesting a distinct target for these peptides in mainly one
of the two different cells in the cortical collecting duct. This
distinct localization would suggest that atrial natriuretic peptides
affect primarily one of the two cells of the cortical collecting duct
in mediating their effects within the kidney.
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